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HIDDEN MARKOV MODELS FOR ALCOHOLISM
TREATMENT TRIAL DATA
BY KENNETH E. SHIRLEY, DYLAN S. SMALL, KEVIN G. LYNCH,
STEPHEN A. MAISTO AND DAVID W. OSLIN
Columbia University, University of Pennsylvania, University of Pennsylvania,
Syracuse University and University of Pennsylvania
In a clinical trial of a treatment for alcoholism, a common response vari-
able of interest is the number of alcoholic drinks consumed by each subject
each day, or an ordinal version of this response, with levels corresponding to
abstinence, light drinking and heavy drinking. In these trials, within-subject
drinking patterns are often characterized by alternating periods of heavy
drinking and abstinence. For this reason, many statistical models for time
series that assume steady behavior over time and white noise errors do not
fit alcohol data well. In this paper we propose to describe subjects’ drinking
behavior using Markov models and hidden Markov models (HMMs), which
are better suited to describe processes that make sudden, rather than gradual,
changes over time. We incorporate random effects into these models using a
hierarchical Bayes structure to account for correlated responses within sub-
jects over time, and we estimate the effects of covariates, including a random-
ized treatment, on the outcome in a novel way. We illustrate the models by
fitting them to a large data set from a clinical trial of the drug Naltrexone.
The HMM, in particular, fits this data well and also contains unique features
that allow for useful clinical interpretations of alcohol consumption behavior.
1. Introduction. A major goal in alcoholism research is to develop models
that can accurately describe the drinking behavior of individuals with Alcohol Use
Disorders (AUDs: alcohol abuse or alcohol dependence), so as to better under-
stand common patterns among them. Clinical trials of treatments for AUDs are
run with the closely related goal of understanding the relationship between a sub-
ject’s alcohol consumption and treatment variables, as well as certain background
variables, like age and sex, and other time-varying variables, like a daily measure
of a subject’s desire to drink and/or stress level [McKay et al. (2006)]. It is of par-
ticular interest to understand the relationship between these variables and relapses
into AUD, as opposed to ordinary alcohol use. In summary, alcohol research is an
area in which statistical models are needed to provide rich descriptions of alcohol
consumption as a stochastic process in such a way that we can make inferences
about the relationship between exogenous variables and drinking. The main focus
Received May 2007; revised July 2009.
Key words and phrases. Hidden Markov models, alcoholism clinical trial, longitudinal data,
mixed effects models, alcohol relapse, MCMC for mixture models.
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of this paper is developing models that are flexible enough to describe a wide va-
riety of drinking behaviors, and are parsimonious enough to allow for clinically
interpretable inferences.
We propose nonhomogeneous, hierarchical Bayesian Markov models and hid-
den Markov models (HMMs) with random effects for AUDs treatment trial data.
Trial subjects’ drinking behavior over time is often characterized by flat stretches
of consistent alcohol consumption, interspersed with bursts of unusual consump-
tion. Markov models and HMMs are well-suited to model flat stretches and bursts,
enabling them to make good predictions of future drinking behavior (compared to
other models). We incorporate covariate and treatment effects into the transition
matrices of the Markov models and HMMs, which allows a rich description of the
evolution of a subject’s drinking behavior over time. The inclusion of random ef-
fects into these models allows them to account for unobserved heterogeneity on the
individual level. Furthermore, the HMM, which this paper focuses on more than
the Markov model, contains features that lend themselves to useful clinical inter-
pretations, and provides a quantitative model of a widely used theoretical model
for relapses known among alcohol researchers as the cognitive-behavioral model.
As an illustration, we fit these models to a large (N = 240 individuals, T = 168
time points) data set from a clinical trial of the drug Naltrexone that was conducted
at the Center for Studies of Addictions (CSA) at the University of Pennsylvania.
We fit the models using MCMC methods, and examine their fits with respect to
various clinically important statistics using posterior predictive checks. These sta-
tistics include such things as the time until a subject consumes his or her first
drink, the proportion of days in which a subject drinks, and various measures of
serial dependence in the data. We also estimate the treatment effect in a novel way
by estimating its effect on transitions between latent states.
This paper builds on recent work in using HMMs for large longitudinal data
sets. Altman (2007) unifies previous work on HMMs for multiple sequences
[Humphreys (1998), Seltman (2002)] by defining a new class of models called
Mixed Hidden Markov Models (MHMMs), and describes a number of methods for
fitting these models, which can include random effects in both the hidden and con-
ditional components of the likelihood. The models we fit are similar to those de-
scribed in Altman (2007), but our data sets are substantially larger, and we choose
a different method for fitting the models, using a Bayesian framework outlined by
Scott (2002). This work also provides another example of using HMMs for health
data, as was done by Scott, James and Sugar (2005) in a clinical trial setting with
many fewer time points than the one examined here.
The rest of the paper is organized as follows: Section 2 introduces the the clini-
cal trial that generated the data to which we fit our models, and discusses existing
models and the motivation for new models. Section 3 introduces the HMM and
Markov model that we fit to the data. Section 4 describes the MCMC algorithm we
used to fit the models and some model selection criteria we considered when com-
paring the fits of each model. Section 5 provides a basic summary of the parameter
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estimates of the models. Section 6 discusses the effects of the treatment and other
covariates in terms of the transition probabilities and the stationary distribution of
the HMM. Section 7 discusses the fit of the HMM via posterior predictive checks
of some common alcohol-related statistics, and compares the fit of the HMM to
that of the Markov model in terms of the serial dependence structure of the data.
Section 8 discusses how the HMM can be used to provide a new definition of a
relapse, which is a well known problem in the alcohol literature. Last, Section 9
provides a summary.
2. Background and data. Before introducing the models we fit, we discuss
the features of the AUD treatment clinical trial from which we collected our data,
some existing models for alcohol data and the motivation for using Markov models
and HMMs.
2.1. Data description. The data set to which we fit our models is from a clin-
ical trial of a drug called Naltrexone conducted at the CSA at the University of
Pennsylvania. It contains daily observations from N = 240 subjects over T = 168
days (24 weeks, or about 6 months). The subjects were volunteers who had been
diagnosed with an AUD, and were therefore prone to greater than average alcohol
consumption and more erratic drinking behavior than individuals without an AUD
diagnosis. The subjects self-reported their alcohol consumption, making measure-
ment error a likely possibility. Immediately prior to the trial, the subjects were re-
quired to abstain from drinking for at least three days as a detoxification measure.
Subjects recorded their daily consumption in terms of a standard scale in alcohol
studies, where “one standard drink” represents 1.5 oz. of hard liquor, or 5 oz. of
12% alcohol/volume wine, or 12 oz. of (domestic US) beer. In order to reduce
the influence of outliers and possible measurement error, it is common [Anton et
al. (2006)] to code the number of drinks consumed as an ordinal variable with
three levels, corresponding to no drinking (0 drinks), light drinking (1–4 drinks)
and heavy drinking (four or more standard drinks for women, five or more stan-
dard drinks for men). A complete description of the trial is available in Oslin et al.
(2008).
A sample series for one of the subjects is plotted in Figure 1, and the entire
collection of 240 time series are represented in Figure 2. The overall frequencies
of the dependent variable are the following: 0 drinks (Y = 1, 68%), 1–4 drinks
(Y = 2, 7%), 4/5 or more drinks for women/men (Y = 3, 8%), with 17% of obser-
vations missing.
We include 4 covariates in the models we fit:
1. Treatment. Half the subjects were randomly assigned to receive the drug Nal-
trexone, and the other half were assigned a placebo.
2. Sex. There were 175 men in the study, and 65 women.
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FIG. 1. The time series plot of alcohol consumption for Subject 34. The vertical axis has tickmarks
at 1 (0 drinks), 2 (1–4 drinks) and 3 (5 or more drinks).
3. Previous drinking behavior. Each study participant was asked to estimate the
proportion of days prior to the study during which they drank, and during
which they drank heavily. We used these two variables, denoted D(i,drink) and
FIG. 2. A representation of the observed alcohol consumption time series for all N = 240 subjects
in the clinical trial. They are approximately sorted from top to bottom (within their treatment group)
in order of increasing alcohol consumption.
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D(i,heavy), to calculate the proportion of days prior to the trial during which
each subject drank moderately, denoted D(i,moderate) = D(i,drink) − D(i,heavy),
and then created a “previous drinking behavior” index, Zi = D(i,moderate) +
2D(i,heavy) ∈ [0,2]. This variable is a univariate summary of a subject’s previ-
ous drinking behavior which is approximately unimodal.
4. Time. We measure time in days from 1,2, . . . , T = 168. Subjects did not nec-
essarily participate during the same stretch of actual calendar days, so this vari-
able is only a measure of the relative time within the clinical trial.
Prior to fitting the models, we scale these 4 input variables to have a mean
of zero and a standard deviation of 1/2, so that the regression coefficients are
comparable on the same scale. The ordinal drink counts and covariates for all 240
subjects are available as supplementary material in Shirley et al. (2009).
2.2. Existing models. Current models for alcohol data range from relatively
simple models that compare univariate summary statistics among different treat-
ment groups to more complex failure time models, linear mixed models and latent
transition models. Wang et al. (2002) provide a good review and a discussion of
why very simple summary statistics are not adequate for modeling drinking out-
comes over time. Some examples of such summary statistics are average number
of drinks per day and percentage of days abstinent. Average drinks per day, for ex-
ample, might not differentiate between one subject who drinks moderately every
day of the week and another subject who abstains from drinking during the week,
and then binges on the weekend. Percentage of days abstinent, on the other hand,
does not differentiate between light and heavy drinking, and does not provide in-
formation about the pattern of abstinence across time.
Wang et al. suggest the use of multivariate failure time models for alcohol data.
These models can be used to predict the amount of time before the next relapse.
One shortcoming of such models is that they require a strict definition of a relapse
in order to define an “event.” Although alcohol researchers agree on a conceptual
definition of a relapse as a failure to maintain desired behavior change, they do not
agree on an operational definition of relapse [Maisto et al. (2003)]. For example, do
two days of heavy drinking separated by a single day of abstinence constitute two
relapses or just one? Does one isolated day of heavy drinking constitute a relapse
or just a “lapse”? Any inference drawn from a multivariate failure time model is
conditional on the definition of a relapse. Maisto et al. (2003) show that the choice
of relapse definition makes a meaningful difference in estimates of relapse rates
and time to first relapse.
McKay et al. (2006) review GEE models for repeated measures alcohol data.
Although GEE models are useful in many ways, they are best suited to estimate
the population mean of drinking given a set of covariates, rather than to make
predictions for an individual given the individual’s covariates and drinking his-
tory. Latent transition models, which are closely connected to HMMs, have been
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proposed in the literature on addictive behavior [e.g., Velicer, Martin and Collins
(1996)]. These models typically require a multivariate response vector at each time
point, and are fit for data with a small number of time points, whereas our data have
a univariate response at each time point and a long time series for each subject.
Mixed effects models are in principle well suited to making individual predic-
tions [McKay et al. (2006)], but a rich structure for the serial correlation must be
considered to accommodate the flat stretches and bursts nature of alcohol data,
something which has not been considered thus far in the alcohol research litera-
ture. This paper introduces two such models—a mixed effects HMM and a mixed
effects Markov model for alcohol data.
2.3. Motivation for a Markov model or HMM. One of the important goals of
this research is to fit a model to alcohol data that can provide a rich description
of the changes in a subject’s drinking behavior through time. A first-order Markov
(chain) model is a suitable starting point in the search for such a model. It models
the observed data at a high resolution—daily observations—as opposed to some
lower-dimensional summary statistic of the data, such as the time until the first
relapse. By modeling the observations themselves, we can infer the distribution of
any lower-dimensional summary statistic we wish after fitting the model. The se-
rial dependence structure of a Markov model, however, is such that it may not be
suitable for data that exhibit long-term dependence.
The HMM is an attractive alternative to the first-order Markov model because
its serial dependence structure allows for longer-term dependence. As we have
stated previously, drinking behavior among individuals following their AUD treat-
ment is erratic, commonly exhibiting flat stretches and bursts, creating long-term
dependence. Longitudinal data of this form suggest that a parameter-driven model
might fit the data better than an observation-driven model. Cox (1981) originally
coined the term parameter-driven for models in which an underlying, potentially
changing “parameter process” determines the distribution of observed outcomes
through time, such that the observed outcomes depend on each other only through
the underlying parameter process. Observation-driven models, on the other hand,
model observed outcomes directly as functions of previously observed outcomes.
State-space models and HMM’s (which are a subset of state-space models) are
widely used examples of parameter-driven models.
A second, very important motivation for the HMM for alcohol data is its po-
tential clinical interpretation: it is a quantitative model that closely corresponds to
a well-developed theoretical model of relapse known as the cognitive-behavioral
model of relapse. This theory suggests that the cause of an alcohol relapse is two-
fold: First, the subject must be in a mental and/or physical condition that makes
him or her vulnerable to engaging in an undesired level of drinking. In other words,
if the subject were given an opportunity to drink alcohol, he or she would be unable
to mount an effective coping response, that is, a way to avoid drinking above some
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desired level (usually abstinence or a moderate level of drinking). A subject’s abil-
ity to cope can depend on time-varying cognitive factors, such as expectations of
the results of drinking, time-varying noncognitive factors, such as level of stress,
desire to drink and social support, and background variables such as age or sex.
The second condition that must be present for a relapse is that the subject encoun-
ters a high-risk drinking situation, which is a setting associated with prior heavy
alcohol use. Common examples are a negative mood, interpersonal problem(s) and
an invitation to drink. McKay et al. (2006) and Marlatt and Gordon (1985) contain
more detailed discussions of the traditional cognitive-behavioral model of relapse,
and Witkiewitz and Marlatt (2004) update Marlatt and Gordon (1985).
The HMM connects to the cognitive-behavioral model of relapse in the follow-
ing way: The hidden states in the HMM correspond to the vulnerability of the
subject to drinking if faced with a high risk situation, and the number of drinks
consumed on a given day is affected by the subject’s vulnerability to drinking on
the given day (the hidden state) and whether the subject faced a high-risk drinking
situation on that day. The conditional distributions of the observations given the
hidden states model the prevalence of high-risk drinking situations for each hid-
den state. Interpreting the HMM this way suggests that relapse is not necessarily an
observable state—it is a hidden state that presumably leads to heavy drinking with
higher probability than other states, but not with certainty. Via this correspondence
to the cognitive-behavioral model of relapse, the HMM has potential to make an
important contribution to the alcohol literature in its ability to provide quantitative
insight into a popular qualitative model for relapse.
3. The models. The data we wish to model consist of categorical observa-
tions Yit ∈ (1,2, . . . ,M), for subjects i = 1, . . . ,N , and time points t = 1, . . . , ni
(where ni = 168 for all subjects in our data set). We also observe the p × 1 co-
variate vectors Xit = (Xit1,Xit2, . . . ,Xitp)′ for each subject at each time point.
We consider two types of models in this paper: (1) a hidden Markov model, and
(2) a Markov model.
3.1. Hidden Markov model. The HMM we fit consists of a mixed effects
multinomial logit model for each row of the hidden state transition matrix, and
multinomial models for (1) the conditional distributions of the observations given
the hidden states, hereafter called the conditional distributions of the HMM, and
(2) the initial hidden state distribution. The model includes an unobserved, discrete
hidden state, Hit ∈ (1,2, . . . , S) for each individual i at each time point t , and we
denote an HMM with S hidden states as an HMM(S).
The hidden state transition matrix is an S × S matrix, in which each row has
probabilities that are modeled using a mixed effects multinomial logit model:
p
(
H(i,t+1) = s|Hit = r,Xit ,αir ,βr
)= exp(αirs + X
′
itβrs)
1 +∑Sk=2 exp(αirk + X′itβrk)
(1)
HMMS FOR ALCOHOL DATA 373
for r = 1, . . . , S, s = 2, . . . , S, i = 1, . . . ,N , and t = 1, . . . , T − 1. For s = 1, the
numerator is set equal to 1, making the first category the baseline category. The ran-
dom intercepts are modeled using normal distributions, where αirs ∼ N(μrs, σ 2rs),
for i = 1, . . . ,N , r = 1, . . . , S, and s = 2, . . . , S.
The inclusion of S(S − 1) random intercepts for each subject means that each
subject’s transition matrix is fully flexible to reproduce every possible set of cell
frequencies for that subject. The regression effects, on the other hand, are “fixed”
effects that are constant across all subjects. They may, however, be time-varying.
The conditional distributions of the HMM are multinomial distributions, where
p(Yit = m|Hit = s,ps) = psm(2)
for m = 1, . . . ,M and s = 1, . . . , S, where ps = (ps1,ps2, . . . , psM) is a vec-
tor of multinomial probabilities, for s = 1, . . . , S. Last, the initial hidden state
distribution for the HMM is a multinomial distribution with probability vector
π = (π1, . . . , πS). For the hidden Markov model, the collection of all parameters
is θ = (α,β,μ,σ ,π,P).
3.2. Markov model. The other model we consider is a first-order Markov
model, in which the set of probabilities in each row of the transition matrix is
defined according to the same model described in Section 3.1, a mixed effects
multinomial logit model. The outcome for individual i at time t + 1, Y(i,t+1), de-
pends on the previous observation for that individual, Yit , in the following way:
p
(
Y(i,t+1) = m|Yit = j,Xit ,αij ,βj
)= exp(αijm + X
′
itβjm)
1 +∑Mk=2 exp(αijk + X′itβjk)
(3)
for j = 1, . . . ,M , m = 2, . . . ,M , i = 1, . . . ,N , and t = 1, . . . , T − 1. As be-
fore, for m = 1, the numerator equals 1. The random intercepts are given normal
distributions, where αijm ∼ N(μjm,σ 2jm), for i = 1, . . . ,N , j = 1, . . . ,M , and
m = 2, . . . ,M .
The initial values, Yi1, for i = 1, . . . ,N , are modeled as i.i.d. draws from
a multinomial distribution with probability vector π = (π1, . . . , πM). For the
Markov model, the collection of all parameters is θ = (α,β,μ,σ ,π).
3.3. Missing data. Following Oslin et al. (2008)’s analysis of the trial we are
considering, we will assume that the missing data is missing at random, that is,
the missingness mechanism is independent of the missing data given the observed
data and covariates. For the HMM, we make the additional assumption that the
missingness mechanism is independent of the hidden states given the observed
data and covariates, in order to do inference on the hidden states as well as the
model parameters [Gelman et al. (2004), Chapter 21]. A sensitivity analysis for
this assumption is a valuable topic for future research, but outside the scope of this
paper. There is a considerable literature on missing data in longitudinal addiction
studies, including Albert (2000, 2002) and Longford et al. (2000), which might
guide one’s choices regarding the design of a sensitivity analysis.
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3.4. Discussion of models. The first-order Markov model is nested within an
HMM with M or more hidden states. Also, an HMM with S hidden states is nested
within an HMM with more than S hidden states. An HMM is a mixture model,
whose mixing distribution is a first-order Markov chain. It has been applied to
problems in numerous fields [for lists of examples, see MacDonald and Zucchini
(1997), Scott (2002) or Cappe, Moulines and Ryden (2005)], but not previously to
alcohol consumption time series data.
4. Model fits and comparison.
4.1. Model fits. We fit the HMM(3) and the Markov model using Metropolis-
within-Gibbs MCMC algorithms whose details are described in the Appendix.
We ran three chains for each model and discarded the first 10,000 iterations of
each chain as burn-in. We used the next 10,000 iterations as our posterior sample
and assessed convergence using the potential scale reduction factor [Gelman et al.
(2004)], and found that Rˆ < 1.02 for all parameters in the models. Visual inspec-
tion of trace plots provide further evidence that the posterior samples converged
to their stationary distributions. The autocorrelation of the posterior samples of β
were the highest of all the parameters, such that total effective sample size from
three chains of 10,000 iterations each was between 200 and 300. The transition
probabilities for each subject and time point, on the other hand, had much lower
autocorrelations, such that for a given transition probability, three chains of 10,000
iterations each yielded a total effective sample size of about 5000 approximately
independent posterior samples. Since transition probabilities are the most impor-
tant quantity of interest in our analysis, the Monte Carlo error associated with our
estimated treatment effects is small.
All the parameters were given noninformative or weakly informative priors,
which are described in the Appendix. The algorithm for both models consisted
of sampling some of the parameters using univariate random-walk Metropo-
lis steps, and others from their full conditional distributions. When fitting the
Markov model, if a subject’s data were missing for tmis steps, we computed the
(tmis + 1)-step transition probability to calculate the likelihood of the current para-
meters given the data, and alternated between sampling Ymis ∼ p(Ymis|Yobs,X, θ)
and θ ∼ p(θ |Yobs,Ymis,X). Likewise for the HMM, we alternated sampling
H ∼ p(H|Yobs,X, θ) and θ ∼ p(θ |Yobs,H,X). We sampled H using a forward-
backward recursion as described in Scott (2002), substituting (tmis + 1)-step tran-
sition probabilities between hidden states when there was a string of tmis missing
observations for a given subject.
The hidden states of an HMM have no a priori ordering or interpretation, and
as a result, their labels can “switch” during the process of fitting the model from
one iteration of the MCMC algorithm to the next, without affecting the likelihood
[Scott (2002)]. We experienced label switching when the starting points for the
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MCMC algorithm were extremely widely dispersed, but when we used more nar-
rowly dispersed starting points, each chain converged to the same mode of the
S! symmetric modes of the posterior distribution. We discuss our procedure for
selecting starting points for the parameters in the MCMC algorithms in the Ap-
pendix.
4.2. Model comparison. We present the DIC of the two models in this sec-
tion, but we ultimately don’t rely on it as a formal model selection criterion. In-
stead we use posterior predictive checks to compare the two models, and combine
this analysis with existing scientific background knowledge to motivate our model
choice, which suggests that the HMM(3) is more promising.
The Markov model converged to a slightly lower mean deviance than the
HMM(3), where the deviance is defined as D(Y, θ) = −2 logp(Y|θ). Table 1
contains a summary of the deviance for both models, where D¯(Y, θ) is the mean
deviance across posterior samples of θ , and D(Y, θ¯) is the deviance evaluated at
the posterior mean, θ¯ . For the Markov model, deviance calculations were done
using the parameter vector θ = (α,β,π), whereas for the HMM(3), the parame-
ter vector θ = (α,β,π,P). That is, for both models, we compute the probability
of the data given the parameters in the likelihood equation, and don’t factor in
the prior probabilities of the random effects, p(α|μ,σ ). The Markov model has a
higher estimated effective number of parameters, pD, and also has a higher DIC,
which is an estimate of a model’s out of sample prediction error [Spiegelhalter et
al. (2002)]. The estimates of pD and DIC had low Monte Carlo estimation error
(approximately ±5), as estimated by recomputing them every 1000 iterations after
burn-in.
Model selection criteria such as BIC and DIC, however, are well known to
be problematic for complicated hierarchical models, mixture models such as an
HMM and models with parameters that have non-normal posterior distributions
[Spiegelhalter et al. (2002), Scott (2002)]. For this reason, we choose not to select
a model [between the Markov model and the HMM(3)] based on formal criteria
such as these. Instead, we examine the fit of each model using posterior predictive
checks and highlight each of their advantages and disadvantages. We ultimately
focus most of our attention on the HMM(3) because of its potential for clinical
interpretability in terms of the cognitive behavioral model of relapse (Section 2.3),
TABLE 1
Summary of the DIC of the models
Model D¯(Y, θ) D(Y, θ¯) pD DIC
Markov 19,871 19,183 688 20,560
HMM(3) 19,902 19,303 599 20,500
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which suggests that a relapse is not equivalent to a heavy drinking episode, but
rather, it may be better modeled as an unobserved state of health.
5. Interpreting the model fits. We begin by looking at the parameter esti-
mates of the Markov model and HMM(3).
5.1. Conditional distributions of the HMM. The hidden states of the HMM(3)
can be characterized by their conditional distributions, which are multinomial dis-
tributions with three cell probabilities, psm = p(Yit = m|Hit = s) for outcomes
m = 1,2,3 and hidden states s = 1,2,3. The posterior distributions of psm are
summarized in Table 2. Each conditional distribution puts most of its mass on a
single outcome, and we therefore label the hidden states according to which out-
come has the largest probability under their associated conditional distributions:
The first hidden state is labeled “Abstinence” (“A”), the second hidden state is la-
beled “Moderate Drinking” (“M”), and the third hidden state is labeled “Heavy
Drinking” (“H”). The Moderate and Heavy Drinking states each leave a small, but
significant (as indicated by their 95% posterior intervals excluding zero) proba-
bility of a different outcome from moderate (Y = 2) and heavy (Y = 3) drinking,
respectively.
5.2. Transition probabilities. The posterior distributions of the parameters as-
sociated with the transition matrices for the Markov model and the HMM(3) are
similar. This is not surprising, considering that if p11 = p22 = p33 = 1, then the
HMM(3) is equivalent to the Markov model, and from Table 2 we see that the
estimates of p11,p22 and p33 are almost equal to 1. We will not discuss the pos-
terior distributions of these parameter estimates here, though, because the form of
the multinomial logit model for each row of the transition matrices makes them
somewhat difficult to interpret. Instead, we present the estimated mean transition
matrices for both models:
QˆMarkov =
⎛
⎝
0.97 0.02 0.01
0.75 0.21 0.04
0.45 0.03 0.52
⎞
⎠ , QˆHMM(3) =
⎛
⎝
0.98 0.01 0.01
0.72 0.26 0.02
0.41 0.02 0.57
⎞
⎠ .(4)
TABLE 2
Conditional Distributions of the HMM(3)
Posterior mean Posterior stand. errors State label
pˆ1 (0.997, 0.003, 0.000) (0.001, 0.001, 0.000) “Abstinence”
pˆ2 (0.026, 0.956, 0.018) (0.012, 0.012, 0.005) “Moderate Drinking”
pˆ3 (0.031, 0.004, 0.966) (0.006, 0.002, 0.007) “Heavy Drinking”
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These are the posterior mean transition matrices for the Markov model and
HMM(3) for a subject with average random intercepts, and the average value for
each covariate: Xi = (0,0,0,0)′. Formally,
QˆModel(j,m) = 1
G
G∑
g=1
( exp (μ(g)jm)
1 + exp (μ(g)j2 ) + exp (μ(g)j3 )
)
for j = 1, . . . ,3, m = 2,3, and posterior samples g = 1, . . . ,G, where for m = 1,
the numerator is replaced by the value 1. Setting the time variable equal to zero
corresponds to calculating the mean transition matrix on day 84 of the 168-day
clinical trial. Note that Sex and Treatment are binary variables, which means that
no individual subject has the exact design matrix used to calculate the transition
probabilities in Equation (4). Later in Section 6 we will more carefully analyze
the transition matrices bearing this in mind, but for now we are only interested in
rough estimates of the transition probabilities.
The estimates of the mean transition probabilities are very similar between the
two models. One interesting feature is that, on average, for both models, the most
persistent state is Abstinence, the second most persistent state is Heavy Drinking,
and the least persistent state is Moderate Drinking. The Moderate Drinking and
Heavy Drinking states don’t communicate with each other with high probability
under either model (for a person with average covariates). We fully analyze the
covariate effects on the transition matrix in Section 6.
5.3. Initial state probabilities. The posterior distributions of the initial state
probability vectors for the two models were nearly identical, where their posterior
means were πˆ = (93.6%,3.4%,3.0%) for both models, and the posterior standard
deviation was about 1.5% for all three elements of π (for both models).
6. The treatment effect. To estimate the effects of covariates, including the
treatment variable, on the transition probabilities of the hidden state transition ma-
trix for the HMM(3) (where a similar analysis could be done for the Markov model
if desired), we perform average predictive comparisons as described in Gelman and
Hill (2007), pages 466–473. The goal is to compare the value of some quantity of
interest, such as a transition probability, calculated at two different values of an in-
put variable of interest, such as Treatment, while controlling for the effects of the
other input variables. Simply setting the values of the other inputs to their averages
is one way to control for their effects, but doing so can be problematic when the
averages of the other inputs are not representative of their distributions, as is the
case for binary inputs, for example. An average predictive comparison avoids this
problem by calculating the quantity of interest at two different values of the input
of interest while holding the other inputs at their observed values, and averaging
the difference of the two quantities across all the observations.
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In the context of the HMM(3), if we denote the input variable of interest by U ,
and consider high and low values of this variable, u(hi) and u(lo), and denote the
other input variables for individual i at time t by Vit , then we can compute the
average difference in transition probabilities calculated at the two values of U as
follows:
Bjm(U) = 1
N(T − 1)
×
N∑
i=1
T −1∑
t=1
[
P
(
H(i,t+1) = m|Hit = j, θ, uit = u(hi),vit )(5)
− P(H(i,t+1) = m|Hit = j, θ, uit = u(lo),vit )]
for j,m = 1, . . . ,3. We call Bjm(U) the average transition probability difference
for input variable U for transitions from hidden state j to hidden state m.
Figure 3 displays 95% posterior intervals for the average transition probability
differences for all four covariates that are incorporated into the transition matrix
of the HMM(3), for all 32 = 9 possible transitions. The treatment, Naltrexone, ap-
pears to have a moderate negative effect on the probabilities of a transition from
Heavy-to-Heavy and Abstinent-to-Heavy, as is evidenced by the fact that the 95%
posterior intervals for these average transition probability differences lie mostly
below zero [the intervals are (−19.9%,2.5%) and (−4.1%,1.1%), respectively].
Heavy-to-Heavy transitions occur, on average, about 9% less often for those us-
ing Naltrexone, and Abstinent-to-Heavy transitions occur, on average, about 1.5%
less often for those using Naltrexone. This is a desired outcome: These intervals
indicate that Naltrexone may be effective in improving certain aspects of drinking
behavior, because a reduction in these transition probabilities would most likely re-
sult in a decrease in heavy drinking, according to the estimated conditional distrib-
utions associated with these hidden states. Conversely, Naltrexone appears to have
a significant positive effect on the probability of a transition from Moderate-to-
Heavy, occurring about 3.5% more often on average for Naltrexone-takers, which,
on average,would lead to increased heavy drinking.
Other covariate effects visible in Figure 3 include the following:
• All else being equal, women are more likely than men to make transitions into
the Moderate and Heavy states.
• Drinking heavily in the past is associated with higher transition probabilities
into the Moderate and Heavy states.
• Transitions into the Moderate and Heavy states are more likely to occur later in
the clinical trial than earlier in the clinical trial.
• The 95% intervals for the average transition probability differences are notice-
ably shorter for transitions out of the Abstinence state, because that is where
subjects are estimated to spend the most time, and with more data comes more
precise estimates.
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FIG. 3. 95% posterior intervals of the average transition probability differences for each of the four
input variables and for each of the nine transition probabilities in the HMM(3). For the binary input
variables Treatment and Sex, we set the high values, u(hi), as Naltrexone and Female, and the low
values, u(lo), as Control and Male, respectively, and for the continuous input variables, Past Drinking
and Time, we set the high and low values to the mean ± 1 sd of their respective distributions.
6.1. Covariate effects on the stationary distribution. To further summarize the
effects of the covariates on drinking behavior, we can compute average station-
ary probability differences instead of average transition probability differences.
This provides a slightly more interpretable assessment of the treatment effect on
drinking behavior because the stationary distribution contains a clinically impor-
tant summary statistic: the expected percentages of time a subject will spend in
each hidden state, given that the HMM is stationary. An effective treatment would
reduce the expected amount of time spent in the Heavy Drinking state.
The model we fit is a nonhomogenous (i.e., nonstationary) HMM, so, by defi-
nition, it does not have a stationary distribution. We would still, however, like to
make inferences about a subject’s long-term behavior conditional on whether or
not he or she took Naltrexone. One strategy for estimating how much time will be
spent in each state is through posterior predictive simulations of the hidden states
themselves. Another strategy, which we discuss here, is to compute the stationary
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FIG. 4. 95% posterior intervals of average stationary probability differences for the three covari-
ates (other than time) incorporated into the HMM(3) transition matrix.
distribution of the hidden state transition matrix on the last day of the trial for all
subjects. This can be interpreted as a way of projecting drinking behavior into the
long-term future without extrapolating the effect of time beyond the clinical trial,
by assuming that each subject has reached a stationary pattern of behavior at the
end of the trial. Figure 4 contains 95% posterior intervals of the average stationary
probability differences for the covariates Treatment, Sex and Past Drinking, where
the HMM(3) is assumed to be stationary beginning on the last day of the trial.
On average, the use of Naltrexone appears to decrease the amount of time spent
in the Heavy drinking state by about 5%, and increase the amount of time spent
in the Moderate drinking state by the same amount. Women and subjects who
drank heavily prior to the trial also are predicted to spend more time in the Heavy
drinking state in the long run. These estimates are consistent with the average
transition probability differences displayed in Figure 3, and provide a slightly more
concise summary of the covariate effects.
6.2. Heterogeneity among individuals. Another important aspect of the model
fit is the degree of heterogeneity that is present among individuals, which is mod-
eled by the random intercepts as well as the covariate effects embedded in the
HMM(3) hidden state transition matrix. To explore this, we calculate the posterior
mean of each of the 32 = 9 transition probabilities for each subject i at a given
time point t ,
Qˆit (r, s) = 1
G
G∑
g=1
P
(
H(i,t+1) = s|Hit = r,Xit ,α(g),β(g),π (g))(6)
for i = 1, . . . ,N , t = 84 (the midpoint of the trial), r, s = 1,2,3, and posterior
samples g = 1, . . . ,G. In Figure 5 we plot density estimates of each of the 32 = 9
sets of N transition probability posterior means (measured at time t = 84).
The density estimates of these posterior mean transition probabilities represent
heterogeneity among individuals from two sources: the random intercepts and the
covariate effects. By comparing Figure 3 to Figure 5, it is clear that the differ-
ences in mean transition probabilities among individuals are larger than the dif-
ferences implied by covariate effects alone. The largest average transition proba-
bility differences, illustrated in Figure 3, were approximately ±0.2, and were due
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FIG. 5. Density estimates of the 32 = 9 sets of posterior mean transition probabilities in the
HMM(3), where the posterior means are calculated for each individual at the midpoint of the trial
(t = 84), and each of the 9 the transition probability densities are therefore estimated using N = 240
data points.
to differences in the subjects’ previous drinking behavior. We see from Figure 5,
however, that the differences between transition probabilities across individuals
is often greater than 0.5, and can be as large as 1, such that a particular transi-
tion is certain for one individual, and has zero probability for another individual.
Specifically, transition probabilities are relatively similar across subjects when the
subjects are in the Abstinent state, but are highly variable across subjects when
the subjects are in the Moderate and Heavy states. If a subject is in the Abstinent
state, their probability of remaining in the Abstinent state for an additional day is
above 80% for most subjects, regardless of the values of his or her observed covari-
ates and random intercepts (which represent the effects of unobserved covariates).
On the other hand, if a subject is in the Moderate or Heavy state, his or her next
transition is highly uncertain: depending on the individual, he or she may have a
very high or a very low probability of remaining in the same state for another day.
The fact that the random intercepts are explaining more variation in the estimated
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transition probabilities than any individual covariate suggests that it might be use-
ful for future studies to record as many additional covariates as possible. Such a
design might reduce the amount of unexplained heterogeneity across individuals
that must be accounted for by the random intercepts. This result also highlights the
need for random effects in this particular model, as well as the need for studying
the inclusion of random effects into HMMs in general, as they can have a profound
effect on the fit of the model.
7. Goodness of fit of the models. In this section we use posterior predictive
checks to examine the fit of the HMM(3) and the difference between the HMM(3)
and the Markov model.
7.1. Mean and variance of drinking days across subjects. As a first check of
the goodness of fit of our model, we performed posterior predictive checks [Gel-
man et al. (2004)] of the mean and variance of the number of moderate and heavy
drinking days across all subjects (a total of four statistics of interest). The specific
steps we took are as follows: For each of these four statistics, we computed its ob-
served value from the data, and denoted this t (Yobs). Then, for posterior samples
g = 1, . . . ,G, we
1. simulated αrep|μ(g),σ (g), where αrep is a set of random effects to represent a
new set of subjects from the population,
2. simulated Hrep|αrep,β(g),π (g),X,
3. simulated Yrep|Hrep,P(g), and
4. computed t (Yrep),
where the parameters superscripted by (g) are taken from the posterior samples
obtained from the MCMC algorithm. By simulating new random effects, αrep,
we are checking to see that the model adequately captures heterogeneity across
subjects. We compared the values of t (Yobs) to the distributions of t (Yrep) for
the four statistics of interest, and found no evidence of a lack of fit; that is, the
observed values of t (Yobs) were not located in the extreme tails of the distributions
of t (Yrep). Table 3 contains summaries of these posterior predictive checks.
7.2. First drinking day. Another common quantity of interest in alcohol re-
search is the time until a subject’s first drink, also known as the first drinking day,
or FDD. This variable is often treated as the primary outcome in clinical trials
for AUD treatments. We performed a posterior predictive check of the mean and
variance of this statistic across subjects using the same steps as are outlined in
Section 7.1. This check relates not only to the heterogeneity of behavior across
subjects, but also to the patterns of drinking behavior across time.
Figure 6 contains plots summarizing the posterior predictive checks of FDD.
Figure 6(a) contains a histogram of the observed values of FDD for all subjects;
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TABLE 3
Summaries of the posterior predictive checks of the mean and variance of moderate and heavy
drinking days. s2mod and s
2
heavy are the variances of the number of moderate and heavy drinking
days across subjects, respectively, and x¯mod and x¯heavy are the means of the number of moderate
and heavy drinking days across subjects, respectively. The middle 5 columns contain the 2.5th,
25th, 50th, 75th and 97.5th quantiles of the distributions of t (Yrep), and the rightmost column
contains the observed values t (Yobs), and the proportion of the simulated statistics that
were less than these values
Statistic 2.5% 25% 50% 75% 97.5% Observed (quantile)
s2mod 335.9 393.5 430.6 477.6 554.6 524.8 (0.92)
s2heavy 400.6 502.9 558.4 608.4 722.7 618.5 (0.78)
x¯mod 9.8 10.5 10.9 11.3 12.1 11.3 (0.73)
x¯heavy 11.6 12.7 13.4 13.9 15.1 13.7 (0.65)
FIG. 6. (a) The histogram of observed FDD; (b) the histogram of simulated values of the mean
FDD across subjects; (c) the histogram of simulated values of the standard deviation of FDD across
subjects; (d) the histogram of the simulated distribution of Never-Drinkers. In each case, the values
calculated from the simulated distributions were computed by ignoring the days that were missing
for each subject, so that the simulated values are directly comparable to the observed values, denoted
by the vertical dotted lines in each figure.
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the empirical distribution is skewed to the right, and contains only 184 points, be-
cause 56 subjects exhibit a combination of missing data or abstinence throughout
the whole trial. Figures 6(b) and 6(c) contain histograms of the simulated distribu-
tions of the mean and standard deviation of FDD across subjects, for the subset of
subjects who drank at least once, with dotted lines representing the observed val-
ues. The observed values lie within the center parts of their simulated distributions,
indicating an adequate fit. Last, Figure 6(d) contains a histogram of the simulated
values of the number of “Never-Drinkers” among the 240 subjects, that is, those
who never drink throughout the course of the clinical trial, via a combination of
abstinence and missing data. The observed number of Never-Drinkers is 56 (out
of 240), but in general, the model reproduces data sets in which there are about
20–50 Never-Drinkers. This indicates a slight lack of fit—there appears to be a set
of individuals among the subjects (who never drink) whose behavior is not well
captured by the model. A similar lack of fit in other settings has been remedied by
the use of a mover-stayer model [Albert (1999), Cook, Kalbfleisch and Yi (2002)],
in which a latent class of subjects is constrained to exhibit constant behavior over
the whole time series, and membership in this class is estimated from the data.
On the other hand, it may be clinically justifiable to suggest that a subject always
has a nonzero probability of drinking, even if in a given sample of days he or she
never drinks. In the fit of the HMM(3), the prior distributions on the random ef-
fects means (μ) virtually prevent any subject from having a transition probability
of zero by design. Transition probabilities can be very small, but never zero.
7.3. Patterns across time. Further posterior predictive checks demonstrate
that the HMM(3) is able to model nonlinear, nonstationary and heteroscedastic
drinking behavior. To see this, we divided the trial period of 24 weeks into 6 blocks
of 4-week time periods, and performed posterior predictive checks on the mean
and variance of abstinent, moderate and heavy drinking days within each time pe-
riod. In other words, we recreated the four posterior predictive checks illustrated
in Table 3 for data in each of six time periods, and extended the analysis to include
the mean and standard deviation of abstinent days across subjects for each time
period.
Figure 7 contains a visual summary of all 36 of these posterior predictive
checks, where the x-axis in each of the six plots is time. The boxplots in each
of the six plots display the distributions of the simulated values of the given sta-
tistics during each time period, and the black lines display the observed values
of these statistics. The plot in the upper left corner, for example, shows that the
observed mean of abstinent days (across subjects) decreased over the course of
the clinical trial, from about 23 days out of a possible 28 days in the first 4-week
time period to about 18 out of 28 days in the last 4-week time period, and that this
decreasing trend is nonlinear. The HMM(3) captures this nonlinear trend, with a
slight underestimate of the mean number of abstinent days toward the end of the
trial (in the last 4–8 weeks). Furthermore, the lower left-hand plot shows that the
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FIG. 7. Posterior predictive checks of the mean and standard deviation of all three drinking out-
comes in each of the six 4-week time periods during the trial. The gray shaded boxplots display the
distributions of simulated values of each statistic, and the black lines display the observed values of
these statistics. For example, for the first four weeks of the trial, the mean number of abstinent days
across subjects was about 23 days, and in 1000 post-burn-in simulations, the value of this statistic
ranged from approximately 21–24 days, indicating no major lack of fit with respect to this statistic.
standard deviation of the number of days of abstinence (across subjects) increases
as the trial progresses, also in a nonlinear way. The HMM(3) adequately models
this heteroscedasticity, with only a slight underestimate of the standard deviation
of abstinent days in the last 8–12 weeks. Regarding moderate and heavy drinking,
the model appears to adequately describe both the mean and standard deviation of
moderate drinking days for each time period, but fails to fully capture the apparent
quadratic trend in the mean and standard deviation of heavy drinking through time
(both of these quantities appear to increase from the beginning of the trial until
the middle of the trial, and then decrease until the end of the trial). The observed
values of these statistics, though, never fall outside of the tails of the simulated
distributions, indicating no major lack of fit. These posterior predictive checks il-
lustrate the flexibility of the HMM as it is formulated in Section 3.1. Note that for
categorical outcomes, the mean and sd are determined by the same sets of parame-
ters, and that the observed percentages of each categorical outcome are negatively
correlated by definition (because more realizations of one outcome results in fewer
realizations of each of the other outcomes), so that the posterior predictive checks
in Figure 7 are not independent.
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7.4. Serial dependence comparison. To analyze the difference between the
Markov model and the HMM(3), we look for patterns among the data in which
one model fits better than the other. One striking such pattern is related to the way
that the two models handle the serial dependence in the data. Their difference is ap-
parent in the posterior distributions of the estimated probabilities (or, equivalently,
the deviances) of certain data points. The HMM(3) fits better than the Markov
model to the third data point in sequences of the form (3,1,3), (1,2,1), (2,3,2),
etc., where two days of equal consumption are interrupted by a single day of a
different level of consumption. The Markov model, on the other hand, fits better
than the HMM(3) to the third data point in sequences of the form (3,1,1), (1,2,2)
and (2,3,3), etc., where the second and third day’s consumption levels are equal
to each other and different from the first day’s consumption.
Consider Figure 8, in which 95% intervals and point estimates of the poste-
rior probabilities of a sequence of outcomes for Subject 186 are plotted for both
the HMM(3) and the Markov model. On day 90, the third day of a (3,1,3) se-
quence, the HMM(3) fits the data better, because the subject’s reported abstinence
on day 89 did not necessarily represent a change in the hidden state during this
sequence. On day 95, on the other hand, the Markov model fits the data better,
because the reported abstinence that day was the first of many days in a pro-
longed sequence of abstinent behavior. In this case both models fit poorly to the
unexpected day of abstinence on day 94, but the Markov model predicts the fol-
lowing day of abstinence with high probability, whereas the HMM(3) does more
smoothing across time, and is therefore “slower” to predict the second abstinent
FIG. 8. Point estimates and vertical 95% posterior intervals for the estimated probabilities of a
sequence of data points for Subject 186 under both models, where the Markov model point estimates
and intervals are drawn with dashed lines. Both models essentially fit equally well to the data in this
sequence except for two points: the HMM(3) fits better to the heavy consumption on day 90, and the
Markov model fits better to the abstinence on day 95.
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day (on day 95). This pattern is generally true for all triplets of the form (i, j, i)
and (i, j, j), where i and j represent observed consumption levels.
In the presence of measurement error—which is plausible given that the sub-
jects self-report their alcohol consumption—and in light of the cognitive behav-
ioral model of relapse, which suggests that a change in one’s alcohol consump-
tion is not necessarily equivalent to a change in one’s underlying health state, the
“smoother” fit of the HMM(3) is an advantage over the Markov model. The notion
that the underlying behavior of individuals with an AUD is relatively steady, and
that the observations are somewhat noisy, is consistent with the cognitive behav-
ioral model of relapse.
7.5. Differences across subjects. To see the different drinking behaviors
across subjects, we simulated sample paths from the fitted model for each sub-
ject using a procedure similar to the 4-step procedure outlined in Section 7.1. This
time, however, instead of simulating new random effects, αrep, from the posterior
distributions of μ and σ to represent a new sample of subjects from the population,
we simply used the posterior samples of α directly to simulate new hidden states,
Hrep, and observations, Yrep (steps 2 and 3 of the procedure). This way each set of
simulated time series represents a new set of realizations for the exact same set of
subjects whose data were observed, and we can make direct comparisons between
the observed data and the simulations for each individual.
Figure 9 displays the observed drinking time series and one randomly drawn
simulated time series for four subjects whose behaviors varied widely from each
other. From the figure it is clear that the random effects in the HMM(3) allow it
to capture a wide variety of drinking behaviors. Here is a summary of these four
drinking behaviors:
1. Subject 89 is almost always abstinent, with occasional days of heavy drinking,
2. Subject 59 drinks heavily in very frequent short bursts (typically for just
1–2 days in a row),
3. Subject 79 drinks heavily on occasion for longer periods of time (10 days in a
row appears typical),
4. Subject 5 drinks moderately for prolonged periods of time.
Each of these four unique drinking behaviors is captured by the HMM(3) through
the random effects in the hidden state transition matrix.
8. A new definition of relapse. The HMM offers a new definition of a re-
lapse: any time point at which the probability is high that a subject is in hidden
state 3, the Heavy Drinking state. There are a variety of ways to estimate the hid-
den states in an HMM, many of which are discussed in Scott (2002). Most methods
can be categorized in one of two ways: They either maximize the marginal proba-
bility of each Hit separately, or they attempt to find the set of sequences of hidden
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FIG. 9. A visual comparison of observed (left column) and simulated (right column) time series
for four subjects whose behavior varied widely. The HMM(3) is able to reproduce a wide variety of
behaviors via its random effects in the hidden state transition matrix.
states H (which we think of as an N ×T array, consisting of a set of N sequences,
each of length T ) that is collectively the most likely (i.e., the mode of the joint
posterior distribution of H). The first method requires the calculation of the mar-
ginal probabilities of each hidden state at each time point, and then estimates the
hidden state for each subject and time point as maxs{P(Hit = s|Y, θ)}. When the
hidden state transition matrix contains zeroes, though, or has high probabilities on
the diagonal (as it does in our case for many individuals), then using the marginal
probabilities to estimate hidden states can result in a sequence that is very unlikely,
or even impossible, because maximizing the marginal probabilities does not fully
account for the dependence between consecutive hidden states [Rabiner and Juang
(1986)]. Such a sequence is not appealing for characterizing relapse periods be-
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cause our goal is to segment a subject’s drinking time series into plausible periods
of in-control drinking behavior as opposed to out-of-control (relapse) drinking be-
havior.
We attempt the second type of hidden state estimation, in which we seek to
find the set of sequences H that is the most likely, given the observed data. In the
Bayesian framework, one way to do this would be to select the sequence H(g) that
occurs most often in our post-burn-in posterior samples g = 1, . . . ,G. With such
a large data set, though, it would require a huge number of MCMC iterations to
ensure that a single realization of H was sampled twice or more. In our posterior
sample, for example, the largest amount of overlap between any two samples of
H was about 93% [that is, the pair of sets (H(i),H(j)) for i, j ∈ (1, . . . ,G) that
had the most elements in common shared about 93% of their elements]. Thus,
to estimate H, we used a different method: we computed the most likely set of
sequences given the observed data and the posterior mean, θ¯ , using the Viterbi
algorithm [Rabiner and Juang (1986)]. This is similar to what is done is most
frequentist analyses of HMMs, in which the Viterbi algorithm is run conditional
on the MLEs of the model parameters to compute the most likely sequence(s) of
hidden states.
Figure 10 shows the observed data and the most likely hidden states for two
subjects. Subject 150 is estimated to be in the Heavy Drinking state from about
Day 10 to about Day 140, despite not drinking on a number of days during that
span. Likewise, Subject 186 is estimated to be in the Heavy Drinking state for a
prolonged period of time despite a few days of abstinence during that time span.
According to the definition of relapse that says any day spent in the Heavy Drink-
ing hidden state is a relapse, these subjects were both in a state of relapse for
a long, continuous period of time. This relapse definition is robust to outliers
and measurement errors in the sense that a single day, or a brief “burst,” among
the observations does not necessarily imply a transition in the most likely hid-
den state sequence. On many days, these two subjects reported a single day of
abstinence, preceded and followed by many consecutive days of heavy drinking.
Some definitions of relapse would be sensitive to these abstinence observations,
and would suggest that the subject was no longer in a state of relapse, whereas the
HMM-based definition of relapse includes these days as well, because the most
likely hidden state sequence remains the same whether those observations were
a 1, 2 or 3, because of the dependence structure across time that the HMM im-
poses.
Using this definition of relapse, a relapse depends on one’s unobservable phys-
ical and mental state of health, rather than directly on one’s drinking behavior.
Choosing which relapse definition is best for a given purpose requires clinical
insight. Currently used definitions of relapse define what patterns of drinking con-
stitute a relapse a priori before looking at the data. There is no consensus on what
patterns constitute a relapse [Maisto et al. (2003)]. An advantage of the HMM ap-
proach is that it starts with a model of drinking behavior and a qualitative definition
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FIG. 10. The most likely sequence of hidden states for Subjects 150 and 186. The dark lines repre-
sent the observed daily drink counts, and the shaded regions represent the estimated hidden state at
each time point, where the hidden states are numbered 1 through 3 as they are in Table 2.
of relapse (e.g., a state in which a subject has a substantial probability of drinking
heavily) and then lets the data decide what patterns of drinking constitute a relapse.
This being said, we found evidence from earlier fits of HMMs to this data that the
HMM-based definitions of relapse are sensitive to the number of hidden states in
the model and the choice of which hidden states are categorized as relapse states.
This choice becomes harder as the number of hidden states grows, because with
more hidden states, the conditional distributions tend to correspond less clearly to
easily identifiable drinking behaviors. Thus, using the HMM definition of relapse
suggested in this section still requires careful thought on the part of the investiga-
tor with respect to (1), the choice of the number of hidden states, and, once that
choice is made, to (2), the choice of which hidden states will be designated as
relapse states.
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9. Discussion and extensions. In this paper we develop a nonhomogenous,
hierarchical Bayes HMM with random effects for data from a clinical trial of an
alcoholism treatment. The model is motivated by data which exhibits flat stretches
and bursts, as well as by the cognitive-behavioral model for relapse that coin-
cides with the structure of the HMM, in which subjects make transitions through
unobservable mental/physical states over time, and their daily alcohol consump-
tion, which is observed, depends on their underlying state. A major strength of the
HMM (and also of the Markov model we propose) is that it models the daily alco-
hol consumption of subjects. Such a model provides a rich description of subjects’
alcohol consumption behavior over time, as opposed to some lower-dimensional
random variable such as the time until a subject’s first relapse, which provides a
narrower view of a subject’s alcohol consumption.
The fit of the model to the data reveals a number of interesting things. The HMM
with three hidden states fits well, and the hidden state transition matrix reveals
that the most persistent state is abstinence, followed by heavy drinking, followed
by moderate drinking. The transition matrices, however, vary widely among sub-
jects, and the models, in general, are able to reproduce a wide variety of drinking
behaviors (see Figure 9). The treatment in the clinical trial we analyzed, Naltrex-
one, appears to have a small, beneficial effect on certain transition probabilities, as
well as on the overall percentage of time one would expect to spend in the heavy
drinking state. Posterior predictive checks reveal that the heterogeneity among in-
dividuals is captured by the random effects in the hidden state transition matrices.
Furthermore, the HMM(3) adequately models nonstationary, nonlinear and het-
eroscedastic drinking patterns across time.
Also, the HMM suggests a new definition of relapse, based on hidden states,
which is conceptually supported by the cognitive-behavioral model of relapse, and
can be compared to existing definitions of relapse to offer new insights into which
patterns of drinking behavior are indicative of out-of-control behavior (i.e., a sub-
stantial probability of heavy drinking).
APPENDIX: MCMC ALGORITHMS TO FIT THE MODELS
Here we present some details of the MCMC algorithms used to fit the models.
A.1. Fitting the Markov model. The Markov model, as was described in
Section 3.2, is essentially composed of M separate multinomial logit models, one
for each row of the transition matrix. The Markov model, however, is substan-
tially more difficult to fit, because the observations given the model parameters
are not i.i.d.; each observation depends on the previous one. We incorporate a data
augmentation step into the Metropolis-within-Gibbs algorithm to fit the Markov
model. First, the priors:
βmjk ∼ N(0,102) for m = 1, . . . ,M, j = 2, . . . ,M, k = 1, . . . , p,(7)
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μmj ∼ N(0,102) for m = 1, . . . ,M, j = 2, . . . ,M,(8)
p(σmj ) ∼ 1 for m = 1, . . . ,M, j = 2, . . . ,M,(9)
π ∼ Dirichlet(1).(10)
We fit the Markov model with the following steps:
1. Initialize the parameters, α(0)ijm,β
(0)
jm, for i = 1, . . . ,N , j = 1, . . . ,M , and
m = 2, . . . ,M , using overdispersed starting values, and initialize μ(0)jm = 0 and
σ
(0)
jm = 1 for j = 1, . . . ,M , and m = 2, . . . ,M .
2. For g = 1, . . . ,G,
(a) Sample Ymis,(g)i |Yobsi ,α(g−1)i ,β(g−1) from its full conditional distribution
for i = 1, . . . ,N .
(b) Sample α(g)ijm|Yobsi ,Ymis,(g)i ,β(g−1)j ,μjm,σjm using a univariate random
walk Metropolis sampler for i = 1, . . . ,N , j = 1, . . . ,M , and m =
2, . . . ,M .
(c) Sample β(g)jmk|Yobs,Ymis,(g),α(g)j using a univariate random-walk Metropo-
lis sampler, for j = 1, . . . ,M , m = 2, . . . ,M , and k = 1, . . . , p, where α(g)j
denotes the N × (M − 1) matrix of random intercepts sampled during iter-
ation g.
(d) Sample μ(g)jm|α(g)jm, σ (g−1)jm from its full conditional normal distribution for
j = 1, . . . ,M and m = 2, . . . ,M , where α(g)jm is the length-N vector of ran-
dom intercepts sampled during iteration g.
(e) Sample σ (g)jm |α(g)jm,μ(g)jm from its full conditional inverse chi-squared distri-
bution for j = 1, . . . ,M and m = 2, . . . ,M .
(f) Sample π |Yobs,Ymis,(g) from its full conditional Dirichlet distribution.
Given the full set of observations for each subject (Yobsi ,Ymisi ), which we
have after step (a) of each iteration, we easily sample the model parameters
[steps (b)–(e) in the algorithm] associated with each row j of the transition matrix
by gathering all the observations {Yit ∈ Y(i,1:(T −1)) :Yit = j}, and then treating the
subsequent observations, Y(i,t+1) ∈ (1,2, . . . ,M), as draws from a multinomial
distribution with probability distributions given in Equation (3), and we do this for
rows j = 1, . . . ,M .
A.2. Fitting the HMM. The priors for the HMM are the same as they are
for the Markov model, except we replace M with S in Equations (7)–(10), and
we add the prior distributions for the parameters in the conditional distributions,
Ps ∼ Dirichlet(1), for s = 1, . . . , S.
The HMM fit requires a similar, but slightly different Metropolis-within-Gibbs
MCMC algorithm from that of the Markov model. We follow Scott (2002) and,
in each iteration of the MCMC algorithm, use a forward-backward recursion to
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evaluate the likelihood, sample the hidden states given the parameters, and then
sample the parameters given the hidden states. The details are as follows:
1. First, initialize all model parameters. For the HMM, we initialize the parame-
ters in a specific way so as to avoid the label-switching problem that is common
to fitting HMMs, and can be triggered by widely dispersed starting points. First,
we fit the HMM with S hidden states using the EM algorithm, without incor-
porating covariates and with complete pooling across subjects. We then set the
values of β(0)rs to zero, and set the values of μ
(0)
rs to the values such that, if all the
N random intercepts α(0)irs , for i = 1, . . . ,N , were set to equal μ(0)rs , the model
would have the same exact transition probabilities as MLE transition probabil-
ities estimated from the EM algorithm. This usually ensures that each chain in
a multichain MCMC algorithm converges to the same mode of the posterior
distribution, which has S! symmetric modes corresponding to the permutations
of the state labels.
2. For g = 1, . . . ,G,
(a) Sample the vector Hi |Yobsi ,β,αi ,P,π from it’s full conditional distribu-
tion using the forward-backward recursion as described in detail in Scott
(2002), for i = 1, . . . ,N .
(b) Sample β , α, μ and σ given H just as they are sampled in steps (b)–(e)
in the Markov model, except replace the indices j and m with r and s,
respectively, for r = 1, . . . , S and s = 2, . . . , S, and replace (Yobs,Ymis)
with H.
(c) Sample P|H,Yobs from its full conditional distribution.
(d) Sample π |H1 from its full conditional Dirichlet distribution, where H1 de-
notes the length-N vector of hidden states at time t = 1.
Data Files Included in the supplementary materials are two data files. The first
file, “y.csv,” contains the ordinal drink counts for each subject on each day, and
has N = 240 rows and T = 168 columns. The second file, “x.csv,” contains the
covariates used to fit our models, and contains sex, treatment and prior drinking
behavior for each subject.
SUPPLEMENTARY MATERIAL
Data Files (DOI: 10.1214/09-AOAS282SUPP; .zip). Included in the supple-
mentary materials are two data files. The first file, “y.csv,” contains the ordinal
drink counts for each subject on each day, and has N = 240 rows and T = 168
columns. The second file, “x.csv,” contains the covariates used to fit our models,
and contains sex, treatment and prior drinking behavior for each subject.
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